META vs RTX: Which Is the Better Buy?

Side-by-side comparison of Meta Platforms, Inc. and RTX Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
Meta Platforms, Inc. Β· Communication Services
$577.22
+33.9% upside to fair value
Grade B High Quality
VS
RTX Corporation Β· Industrials
$185.60
-25.2% upside to fair value
Grade D
QuantHub Verdict
META has more upside to fair value (+33.9%). META trades at a lower forward P/E (20.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric META RTX
Current Price $577.22 $185.60
Fair Value Estimate $772.86 $138.81
Upside to Fair Value +33.9% -25.2%
Market Cap $1,465.2B $249.9B
Forward P/E 20.6x 34.3x
EV / EBITDA 13.5x 18.3x
Price / Sales 6.8x 2.8x
Price / FCF 30.4x 29.9x
Revenue Growth YoY +33.1% +8.7%
Gross Margin 81.9% 20.2%
Operating Margin 41.2% 10.9%
Return on Equity 33.2% 11.2%
Dividend Yield 0% 0%
FCF Yield 3.29% 3.34%
Analyst Consensus Strong Buy Buy
Investment Thesis
META β€” Meta Platforms, Inc.
Meta Platforms, Inc. operates a dominant family of apps generating nearly all its revenue from advertising, supported by a massive user base and strong network effects. The company exhibits high business quality with 33.2% ROE, 33.1% revenue growth in the most recent quarter, and 60.9% earnings growth in the most recent quarter, reflecting robust profitability and growth. Despite these strengths,…
RTX β€” RTX Corporation
RTX Corporation is a leading aerospace and defense company with a strong competitive moat driven by scale and an installed base in commercial aerospace via Pratt & Whitney and Collins Aerospace, and defense through Raytheon. The company benefits from a large multi-year backlog of approximately $270 billion supporting steady cash flow and mid-single-digit organic growth. Despite solid revenue grow…
Accumulation Zones
Metric META RTX
Zone Low $579.64 $104.11
Zone High $656.93 $117.99
In Buy Zone? Yes No
← META Research    RTX Research β†’    All Research